Biological AgingINSPIRENCT04224038
The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform
An observational study of Biological Aging, run by University Hospital, Toulouse at 1 site in France.
Trial summary
Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of… Read more about this study
- Who is it for?
- Ages 30 years and olderHealthy volunteers can take part
- Conditions the study is for
- Biological Aging
- What is being tested?
- The Inspire Bio-resource Research Platform for Healthy Aging
- How many people
- 1,000 participants
- Where
- 1 siteFrance
- Study dates
- 16 Oct 2019to 31 Oct 2033
- How long will I take part?
- 10 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Recruitment will be stratified per 10-year age groups, oversampling older people in order to be able to investigate major clinical events (eg, declines on IC, onset of age-related diseases)
Who may be able to join
- Aged 30 years-old or over;
- Both sexes
- Affiliated to a social security scheme
Who cannot join
- severe disease compromising life expectancy at 5 years;
- Deprived of their liberty by administrative or judicial decision, or under guardianship
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
University Hospital Toulouse
Toulouse, 31059
Bruno Vellas, MD, 05.61.77.70.47 ext. 33, vellas.b@chu-toulouse.fr
Sophie Guyonnet, 5 61 77 70 43 ext. 33, guyonnet.s@chu-toulouse.fr
About this study
Official title: The Inspire Bio-resource Research Platform for Healthy Aging
Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.
Read the detailed description
This is a 10-year observational study. The study will be performed in Occitania Region. Once a year, a complete data collection will be performed in the Gerontopole of Toulouse, in participants' home and health centers by the Gerontopole mobile research team, and in selected Gerontopole's collaborating centers in Occitania.
Between yearly waves of data collection, participants will have their intrinsic capacity domains monitored (with or without the help of a caregiver) each 4-month through the use of either an app developed in collaboration with World Health Organization (WHO) or a web platform; or through a phone call by a clinical/research nurse. For the first self-monitoring of IC at four months, all participants will be contacted by a research/clinical nurse by phone; this call will inform about how participants measured their capacity and/or help them to do it. After this first 4-month phone call, participants capable of correctly self-monitoring their IC through the app will no longer be systematically contacted by phone. Once IC declines are confirmed, participants will have a thorough clinical assessment and blood sampling; such information will allow us to investigate the response of markers of aging at the time declines are detected. Those needing usual care, will be followed according to WHO framework recommendations proposed for Integrated Care for Older Adults (ICOPE).
- Conditions
- Biological Aging
- Being tested
- The Inspire Bio-resource Research Platform for Healthy Aging
- Keywords
- Geroscience, biological aging and identifying targetable biomarkers, The Inspire Bio-resource Research Platform for Healthy Aging, Aged 30 years-old or over, age-related chronic diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The Inspire Bio-resource Research Platform for Healthy AgingOther
Several follow-up visits will be undertaken during the 10-year time frame of this project. Some of these visits are not regularly scheduled and will be conditioned by the remote monitoring of intrinsic capacity (IC) and the onset of other major clinical conditions. Other visits correspond to the regularly scheduled (yearly or every two years (biannual visits), depending on the outcome measures) waves of data collection.
What is being measured
The primary outcome is the main question the study is designed to answer.
Data collection of key variables and biospecimens
The main outcome of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and intrinsic capacities (cognition, mobility, nutrition, hearing and visual capacities, psychological capacity) evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.
Measured: through study completion, an average of 10 years
Secondary outcomes (20)
Identification of (a set of) biomarkers of aging through the constitution of a comprehensive biobank comprising: blood, saliva, urine, nasopharyngeal swabbing, skin biopsies and surface samples, dental plaque, faeces, hair bulb.
- Markers of aging: The identification of (a set of) markers of aging will be allowed from the constitution of a large dataset of clinical, para-clinical and digital data as well as a comprehensive biobank comprising: blood, saliva, urine, nasopharyngeal swabbing, skin material (swabbing, stripping, biopsies), dental plaque, feces, hair bulb.
In this part of the study, we will take advantage of three complimentary approaches to look for the best markers of aging: without a priori approach (omics: transcriptomics, proteomics, lipidomics); semi a priori approach (field-specific omic. I.e. metabolism, inflammation, cell cycle, mitochondrial network…); and targeted approach (pre-identified targets).
Measured: through study completion, an average of 10 years
measure intrinsic capacity domains with questionnaire in ICOPE App (developed in collaboration with W.H.O.)
Icope app (developed in collaboration with W.H.O.) for smartphone and tablet to measure intrinsic capacity domains. This app will be used for the remote (at-distance) evaluation and monitoring (self-monitoring, monitoring by a caregiver, or a healthcare provider) of intrinsic capacity domains; for the monitoring, we will use only the Icope Step 1. When declines are detected in the Icope Step 1, we will use the Icope Step 2 (data collected by research nurses in a home visit or at the research facility) to confirm the decline and, then, look for the causes determining such declines.
Measured: through study completion, an average of 10 years
Basic and instrumental activities of daily living.
Basic and instrumental activities of daily living (ADL). Basic ADLs will be assessed using the 6-item (eg, bathing, feeding, dressing) Katz scale; instrumental ADLs (IADL) will be assessed using the 8-item (eg, cooking, manipulating money) Lawton scale. These variables are measured as a clinical measurement of functional ability and, thus, healthy aging in late ages, according to WHO definition.
Measured: through study completion, an average of 10 years
Mini-nutritional assessment and food frequency questionnaire.
Mini-nutritional assessment (MNA) and food frequency questionnaire. Nutritional status will be evaluated using the MNA (see Vitality description in Icope Step 2). A short (12-item; the question on physical activity has been removed since already investigated using other assessment tools in this project) food frequency questionnaire will be used to assess dietary quality. Nutritional status and diet may affect both intrinsic capacity domains and potential biomarkers of aging.
Measured: through study completion, an average of 10 years
Lifestyle questionnaires
. Lifestyle questionnaires:
- Physical activity (PA) and sedentary time: Based on the International Physical Activity Questionnaire (IPAQ) long form.
- Smoking: This will be evaluated by two questions: Do you currently smoke: any tobacco product? ; e-cigarettes? Responses will be anchored by the terms: daily; weekly, but not daily; less often than weekly; not at all.
- Alcohol consumption: This will be evaluated by a question of the food frequency questionnaire
- Solar exposure: Sun Protection and Exposure Habits Questionnaires
Measured: through study completion, an average of 10 years
ActivPAL: objectively physical activity parameters.
Objectively measured physical activity (PA) and sleep parameters. This will be assessed with an activPal activity monitor. Participants will wear the activPal for one week every two-years and will bring it back personally to the research facilities. Attention will be paid for participants wearing the activity monitor always during the same season to avoid bias related to seasonal changes. PA is one of the most important behaviors for healthy aging, being associated with both intrinsic capacity domains and biomarkers. Sleep changes are often associated with aging and may affect healthy aging.
Measured: through study completion, an average of 10 years
Self-reported visceral pain.
Visceral pain. This will be assessed with a 4-item self-reported questionnaire. This questionnaire is particularly important for investigations on biomarkers from feces.
Measured: through study completion, an average of 10 years
Participant-reported outcome for cognition (CFI)
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Participant-reported outcome for mobility
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Participant-reported outcome for fatigue
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Participant-reported outcome for social isolation (PROMIS)
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Participant-reported outcome for SARQoL.
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Participant-reported outcome for cognition (CFI) and mobility, fatigue, and social isolation (PROMIS), and SARQoL.
Patient reported outcome measures (PROM). Four PROMs, covering cognition and mobility (the two functions that largely determine disability and increased healthcare costs), the overall feeling of fatigue and social isolation. All of them are validated tools for cognition, we will use the Cognitive Function Instrument (CFI), a 14-item questionnaire with score varying from 0 to 14, higher is worse. All the other three PROMs come from the NIH-funded initiative "Patient-reported outcomes measurement information system"
Measured: through study completion, an average of 10 years
Oral Health Assessment Tool (OHAT).
Oral Health Assessment Tool (OHAT) provides a global overview of oral health. It is composed of 8 items: lips, tongue, gum-mucosa, saliva, natural teeth, prostheses, oral hygiene and pain. Each item is scored 0, 1 or 2. A score of 0 indicates the absence of degradation, a score of 2 indicates a significant presence of degradation, a score of 1 indicates that there is a remarkable modification without a significant or widespread degradation. The minimum score is 0 (satisfactory oral status) and the maximum score is 16 (degraded oral status).
Measured: through study completion, an average of 10 years
Short physical performance battery and 30-sec chair rise test.
Short physical performance battery (SPPB) and 30-sec chair rise test. The SPPB will be evaluated. With the participants' consent, performance in the SPPB tests will be video-recorded using standard cameras placed in three different angles in the room: the images will be analyzed to look for digital markers of aging through the patterns of motor function and subsequent subjects risk-stratification. The number of chair rises within 30secwill also be assessed in a fraction of participants. These measurements provide clinical information about mobility.
Measured: through study completion, an average of 10 years
The mini-mental state examination (MMSE)
The Mini-mental state examination (MMSE) and neuropsychological tests. The MMSE is a scale that provides total scores ranging from 0 to 30 (higher values represent better cognitive function). Besides the MMSE, in subjects less than 70 years-old the following neuropsychological tests will be used: free and total recall of the Free and Cued Selective Reminding Test, the Digit Symbol Substitution Test, score from the Wechsler Adult Intelligence Scale-Revised, and the Category Naming Test (2-minute category fluency in animals); when combined in a composite Z-score, these variables provide accurate information about participants' cognitive function.
Measured: through study completion, an average of 10 years
neuropsychological tests.
The Mini-mental state examination (MMSE) and neuropsychological tests. The MMSE is a scale that provides total scores ranging from 0 to 30 (higher values represent better cognitive function). Besides the MMSE, in subjects less than 70 years-old the following neuropsychological tests will be used: free and total recall of the Free and Cued Selective Reminding Test, the Digit Symbol Substitution Test, score from the Wechsler Adult Intelligence Scale-Revised, and the Category Naming Test (2-minute category fluency in animals); when combined in a composite Z-score, these variables provide accurate information about participants' cognitive function.
Measured: through study completion, an average of 10 years
Skin elasticity (cutometer measurement)
Skin elasticity (cutometer measurement). This measures the bio-mechanical properties of the skin by applying mechanical stress to the skin. The measuring principle is based on suction and elongation. A device will be used to generate a negative pressure which can vary between 20 and 500 mbar. The area of the skin to be measured is drawn into the probe opening by this pressure. The depth of skin penetration inside the probe opening is determined by an optical measurement system. The stress can be exerted at different depths of the skin: the 2mm probe solicits the skin at the superficial dermis; the 6mm probe engages the skin more deeply, at the level of the deep dermis, at the limit of the hypodermis.
Measured: through study completion, an average of 10 years
Dual Energy X-ray absorptiometry
Whole body magnetic resonance to measure the Isokinetic muscle strength with Dual Energy X-ray absorptiometry (DEXA°
Measured: through study completion, an average of 10 years
maximum oxygen consumption
maximum oxygen consumption (VO²max) and aerobic power (blood sampling before and after the effort).
Measured: through study completion, an average of 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2020
- Study start16 Oct 2019
- Primary completion16 Oct 2031 (estimated)
- Study completion31 Oct 2033 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Biological AgingStudies of the same condition, open and under way.
- More trials run by University Hospital, ToulouseThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- University Hospital, Toulouse
- Sponsor type
- University, hospital or other
- Collaborators
- European Regional Development Fund
- Responsible party
- Sponsor
- Investigators
- Bruno VELLAS, MD, Principal investigator, University Hospital of Toulouse
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04224038
- Sponsor's protocol ID
- RC31/19/0236
- Acronym
- INSPIRE
- Status last verified
- Nov 2023
- First submitted
- 15 Oct 2019
- Last updated
- 21 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Peyrusque E, Michel E, Catalano C, Aubertin-Leheudre M, Rolland Y, Yuste A, Gonzalez-Bautista E, Abellan van Kan G; IHU HealthAge INSPIRE/Open Science group. Age- and sex-related distribution of 30-second chair stand test performance across adulthood: Findings from the INSPIRE-T cohort. Arch Gerontol Geriatr. 2026 Sep 23;152:106422. doi: 10.1016/j.archger.2026.106422. Online ahead of print.
PubMed 42822167Cabrol A, Shourick J, Coley N, Oustric S, Guyonnet S, Vellas B, Escourrou E, Andrieu S; IHU HealthAge INSPIRE/Open Science study group. Feeling Younger as an Indicator of Better Overall Intrinsic Capacities in the INSPIRE-T Cohort. Int J Geriatr Psychiatry. 2026 May;41(5):e70220. doi: 10.1002/gps.70220.
PubMed 42059106Bellelli F, Raffin J, Cesari M, Guyonnet S, Furman D, Rolland Y, Vellas B, de Souto Barreto P; IHU HealthAge INSPIRE Platform Group; IHU HealthAge Open Science group. The association of pain with intrinsic capacity and the moderating role of inflammation in France: a cross-sectional analysis of the INSPIRE-T project. Lancet Healthy Longev. 2025 Dec;6(12):100798. doi: 10.1016/j.lanhl.2025.100798. Epub 2025 Dec 5.
PubMed 41360071
Study at a glance
From the registry record, last updated by the sponsor on 21 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Inspire Bio-resource Research Platform for Healthy Aging
- ClinicalTrials.gov ID
- NCT04224038
- Acronym / sponsor ID
- INSPIRE / RC31/19/0236
- Conditions
- Biological Aging
- Keywords
- Geroscience, biological aging and identifying targetable biomarkers, The Inspire Bio-resource Research Platform for Healthy Aging, Aged 30 years-old or over, age-related chronic diseases
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University Hospital, ToulouseUniversity, hospital or other
- Collaborators
- European Regional Development Fund
- Study start
- 16 Oct 2019 (actual)
- Primary completion
- 16 Oct 2031 (estimated)
- Study completion
- 31 Oct 2033 (estimated)
- First posted
- 13 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.
Detailed description
This is a 10-year observational study. The study will be performed in Occitania Region. Once a year, a complete data collection will be performed in the Gerontopole of Toulouse, in participants' home and health centers by the Gerontopole mobile research team, and in selected Gerontopole's collaborating centers in Occitania.
Between yearly waves of data collection, participants will have their intrinsic capacity domains monitored (with or without the help of a caregiver) each 4-month through the use of either an app developed in collaboration with World Health Organization (WHO) or a web platform; or through a phone call by a clinical/research nurse. For the first self-monitoring of IC at four months, all participants will be contacted by a research/clinical nurse by phone; this call will inform about how participants measured their capacity and/or help them to do it. After this first 4-month phone call, participants capable of correctly self-monitoring their IC through the app will no longer be systematically contacted by phone. Once IC declines are confirmed, participants will have a thorough clinical assessment and blood sampling; such information will allow us to investigate the response of markers of aging at the time declines are detected. Those needing usual care, will be followed according to WHO framework recommendations proposed for Integrated Care for Older Adults (ICOPE).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 10 Years
Who may qualify
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Recruitment will be stratified per 10-year age groups, oversampling older people in order to be able to investigate major clinical events (eg, declines on IC, onset of age-related diseases)
Key inclusion criteria (3 listed)
- Aged 30 years-old or over;
- Both sexes
- Affiliated to a social security scheme
Key exclusion criteria (2 listed)
- severe disease compromising life expectancy at 5 years;
- Deprived of their liberty by administrative or judicial decision, or under guardianship
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The Inspire Bio-resource Research Platform for Healthy AgingSeveral follow-up visits will be undertaken during the 10-year time frame of this project. Some of these visits are not regularly scheduled and will be conditioned by the remote monitoring of intrinsic capacity (IC) and the onset of other major clinical conditions. Other visits correspond to the regularly scheduled (yearly or every two years (biannual visits), depending on the outcome measures) waves of data collection. | Other | – |
Primary outcome
Data collection of key variables and biospecimens
Time frame: through study completion, an average of 10 years
The main outcome of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and intrinsic capacities (cognition, mobility, nutrition, hearing and visual capacities, psychological capacity) evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.
20 secondary outcomes
Identification of (a set of) biomarkers of aging through the constitution of a comprehensive biobank comprising: blood, saliva, urine, nasopharyngeal swabbing, skin biopsies and surface samples, dental plaque, faeces, hair bulb.
Time frame: through study completion, an average of 10 years
measure intrinsic capacity domains with questionnaire in ICOPE App (developed in collaboration with W.H.O.)
Time frame: through study completion, an average of 10 years
Basic and instrumental activities of daily living.
Time frame: through study completion, an average of 10 years
Mini-nutritional assessment and food frequency questionnaire.
Time frame: through study completion, an average of 10 years
Lifestyle questionnaires
Time frame: through study completion, an average of 10 years
ActivPAL: objectively physical activity parameters.
Time frame: through study completion, an average of 10 years
Self-reported visceral pain.
Time frame: through study completion, an average of 10 years
Participant-reported outcome for cognition (CFI)
Time frame: through study completion, an average of 10 years
Participant-reported outcome for mobility
Time frame: through study completion, an average of 10 years
Participant-reported outcome for fatigue
Time frame: through study completion, an average of 10 years
Participant-reported outcome for social isolation (PROMIS)
Time frame: through study completion, an average of 10 years
Participant-reported outcome for SARQoL.
Time frame: through study completion, an average of 10 years
Participant-reported outcome for cognition (CFI) and mobility, fatigue, and social isolation (PROMIS), and SARQoL.
Time frame: through study completion, an average of 10 years
Oral Health Assessment Tool (OHAT).
Time frame: through study completion, an average of 10 years
Short physical performance battery and 30-sec chair rise test.
Time frame: through study completion, an average of 10 years
The mini-mental state examination (MMSE)
Time frame: through study completion, an average of 10 years
neuropsychological tests.
Time frame: through study completion, an average of 10 years
Skin elasticity (cutometer measurement)
Time frame: through study completion, an average of 10 years
Dual Energy X-ray absorptiometry
Time frame: through study completion, an average of 10 years
maximum oxygen consumption
Time frame: through study completion, an average of 10 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Nov 2023.
- Derived from this study: PubMed 42822167Peyrusque E, Michel E, Catalano C, Aubertin-Leheudre M, Rolland Y, Yuste A, Gonzalez-Bautista E, Abellan van Kan G; IHU HealthAge INSPIRE/Open Science group. Age- and sex-related distribution of 30-second chair stand test performance across adulthood: Findings from the INSPIRE-T cohort. Arch Gerontol Geriatr. 2026 Sep 23;152:106422. doi: 10.1016/j.archger.2026.106422. Online ahead of print.
- Derived from this study: PubMed 42059106Cabrol A, Shourick J, Coley N, Oustric S, Guyonnet S, Vellas B, Escourrou E, Andrieu S; IHU HealthAge INSPIRE/Open Science study group. Feeling Younger as an Indicator of Better Overall Intrinsic Capacities in the INSPIRE-T Cohort. Int J Geriatr Psychiatry. 2026 May;41(5):e70220. doi: 10.1002/gps.70220.
- Derived from this study: PubMed 41360071Bellelli F, Raffin J, Cesari M, Guyonnet S, Furman D, Rolland Y, Vellas B, de Souto Barreto P; IHU HealthAge INSPIRE Platform Group; IHU HealthAge Open Science group. The association of pain with intrinsic capacity and the moderating role of inflammation in France: a cross-sectional analysis of the INSPIRE-T project. Lancet Healthy Longev. 2025 Dec;6(12):100798. doi: 10.1016/j.lanhl.2025.100798. Epub 2025 Dec 5.
- Individual participant dataSharing planned: Undecided
Related trials for Biological Aging
Not yet recruiting
Fecal Microbiota Transplantation (FMT) to Slow Biological Aging
Aging, Healthy, Aging and Cognitive Health
Active, not recruitingObservational study
MCR Syndrome in Quebec : Results From NuAge Study
Motoric Cognitive Risk Syndrome, Aging Disorder
Enrolling by invitationPhase 2
Tirzepatide and Organ-specific Biological Aging
Longevity, Preventive Medicine
Active, not recruiting
Emotional Well-being and Measures of Healthy Aging
Aging, Aging, Healthy
Not yet recruitingObservational study
Biological Aging Following Full-Arch Implant-Supported Fixed Rehabilitation in Edentulous Patients
Edentulism, Biological Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Bruno VELLAS, MD principal investigator
University Hospital of Toulouse
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Biological Aging, run by University Hospital, Toulouse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 21 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bruno VELLAS, MD (5 61 77 70 47 ext. +33, vellas.b@chu-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Data collection of key variables and biospecimens (time frame: through study completion, an average of 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04224038, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2023.